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to the editor: 
 
The case definition of croup given
by Williams et al. in their study of metapneumovi-
rus (Jan. 29 issue)
 
1 
 
seems misleading. The authors
state that croup is an “acute lower respiratory tract
infection characterized by hoarseness, cough, and
stridor.” On the contrary, croup is classified as an
acute upper-airway disease in several textbooks of
pediatrics.
 
2-4
 
 Recognizing croup as an important
cause of acute upper-airway obstruction and its
pertinent features, as distinct from life-threatening
bacterial epiglottitis, is the classic point made in
medical teaching worldwide.
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to the editor: 
 
Williams et al. show that “human
metapneumovirus infection is a leading cause of
respiratory tract infection in the first years of life,
with a spectrum of disease similar to that of respi-
ratory syncytial virus.” In a surveillance study per-
formed from November 1, 2002, to March 31, 2003,
among 1331 healthy children younger than 15
years of age who were seen for acute respiratory in-
fection in an emergency department in Milan, Italy,
we found evidence of human metapneumovirus in
41 children (3.1 percent), of respiratory syncytial
virus in 117 (8.8 percent, P<0.001 for the compari-
son with human metapneumovirus), and of influ-
enzavirus in 209 (15.7 percent; P<0.001 for the
comparison with human metapneumovirus) (Ta-
ble 1). Although the overall prevalence of human
metapneumovirus in our study population ap-
peared to be lower than the prevalence of respirato-
ry syncytial virus and that of influenzavirus, we
showed that this pathogen has multiple effects. We
confirmed that infection with human metapneu-
movirus has clinical characteristics similar to those
of infection with respiratory syncytial virus,
 
1,2
 
 but
its socioeconomic effect appeared to be greater
than that of respiratory syncytial virus infection
and similar to that of influenzavirus infection.
 
3,4
 
We would like to know whether the authors ob-
served the same socioeconomic burden on chil-
dren and their families in association with human
metapneumovirus infection.
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the authors reply: 
 
In response to Dr. Ho: we agree
that the croup is usually poorly defined, partly be-
cause of differences between anatomical and physi-
ological descriptions of this illness. Two standard
textbooks of pediatrics define croup, or laryngotra-
cheobronchitis, as both a cause of “upper airway ob-
struction” and “lower respiratory tract” infection.
 
1,2
 
The classic pathophysiology involves subglottic tra-
cheal edema (the “steeple sign” seen on radiographs
of the airway). The World Health Organization de-
fines lower respiratory tract infection as the pres-
ence of tachypnea, retractions, stridor, wheezing, or
apnea.
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 We think that recognition of croup as a dis-
tinct clinical syndrome is more valuable than a def-
inition based on anatomical terms and define it as
such in our article. There are an estimated 65,000
annual hospitalizations for croup in children less
than five years old in the United States, thus war-
ranting such a distinction and underscoring the
importance of croup as a clinical entity.
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In response to the interesting data presented by
Dr. Principi and colleagues: information about the
age distribution of the patients they describe would
help in the interpretation of the data. As we state in
our article, all the children we studied were less
than five years old and thus not in school. We did
not collect data on parents’ time off from work or
other socioeconomic costs associated with illness-
es due to human metapneumovirus infection. How-
ever, since the mean duration of symptoms before
medical attention was sought was 4.4 days, and 37
percent of the children had concomitant acute oti-
tis media, it is likely that there is a significant socio-
economic burden associated with disease caused
by human metapneumovirus, as has been described
for other respiratory viruses.
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Finally, we would like to clarify the financial
support of our research. The work was supported
by grants (T-32 AI07474 and R03 AI054790 [both
to Dr. Williams] and R00095 [to the General Clini-
 
* RSV denotes respiratory syncytial virus, and hMPV human metapneumovirus.
† P<0.001 for the comparison with influenzavirus-positive children.
 
‡ P<0.05 for the comparison with RSV-positive children.
 
Table 1. Clinical Characteristics and Outcomes among Children Seen in the Emergency Department 
for Acute Respiratory Infection and Effects among Their Household Contacts, According to Viral RNA Detection.*
Characteristic
hMPV-Positive 
(N=41)
RSV-Positive 
(N=117)
Influenzavirus-
Positive
(N=209)
 
Clinical presentation — no. (%)
Common cold
Pharyngitis
Acute otitis media
Croup
Acute bronchitis
Wheezing
Pneumonia
3 (7.3)
11 (26.8)
5 (12.2)
3 (7.3)
4 (9.8)
10 (24.4)†
5 (12.2)
20 (17.1)
20 (17.1)
10 (8.5)
4 (3.4)
15 (12.8)
30 (25.6)†
18 (15.4)
43 (20.6)
73 (34.9)
34 (16.3)
7 (3.3)
20 (9.6)
14 (6.7)
18 (8.6)
Clinical outcome
Hospitalization — no. (%)
Lost school days — no.
Median
Range
2 (4.9)
10
3–15
16 (13.7)
10
3–12
11 (5.3)
12
5–15
Effects among household contacts
Similar disease — no./total no. (%)
Lost work days — no.
Median
Range
Lost school days — no.
Median
Range
18/149 (12.1)‡
4
2–10‡
4
3–15‡
20/420 (4.8)
2.5
2–7
2
2–4
74/767 (9.6)‡
4
1–10‡
5
1–15‡
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Monkeypox in the Western Hemisphere
 
to the editor: 
 
Infection control was a major issue
for investigators attempting to minimize the emer-
gence of monkeypox in the United States, as report-
ed by Reed et al. (Jan. 22 issue).
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 On June 7, 2003,
three Illinois residents with a febrile rash syndrome
presented to a community hospital. Hospital staff
reported the cases that evening to the Illinois De-
partment of Public Health, which recommended
diagnostic testing, collection of contact informa-
tion, and admission under contact and airborne
precautions.
Infection control was efficiently implemented,
despite the absence of preexisting policies specific
to this pathogen and uncertainty regarding best
practices for the prevention of person-to-person
transmission.
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 The hospital’s participation in the
Top Officials 2 (TOPOFF 2) bioterrorism exercise
in May 2003,
 
3
 
 smallpox training activities, and past
management of an imported case of Lassa fever
 
4
 
 en-
hanced the execution of infection-control protocols.
This outbreak tested a hospital’s preparedness
to respond to an unusual communicable agent.
Had the outbreak been larger, the hospital’s isola-
tion facilities would have been insufficient. Hospi-
tals should critically evaluate their capacity to imple-
ment rapid syndrome-based isolation precautions
for emerging disease outbreaks.
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to the editor: 
 
In their report on the U.S. monkey-
pox outbreak (72 cases), Reed et al. cite African
outbreaks of 23 and 88 cases. By doing so, the au-
thors risk minimizing the magnitude of the prob-
lem in Africa, where the disease has been endemic
since the 1970s, with multiple outbreaks, includ-
ing one outbreak of 419 cases in 1996–1997.
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 The
large size of this African outbreak may have resulted
from increased contact with animals in a popula-
tion of persons displaced by civil war.
 
2
 
 High rates
of human exposure to monkeypox may occur in
other scenarios, such as the infection of wild ro-
dents in U.S. cities.
The animal reservoir for human monkeypox re-
mains unknown.
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 Although prairie dogs are the
probable source of transmission in most U.S. cases,
there has been human transmission from other spe-
cies. A rabbit (Leporidae family) that was exposed
to a diseased prairie dog was implicated as the
source of human infection in at least one U.S. case.
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